Key result
Admission HbA1c levels were significantly positively correlated with the number of affected coronary vessels with significant stenosis in both diabetic and nondiabetic patients with acute myocardial infarction, but showed no significant association with long-term clinical outcomes.
Why the study?
Does admission HbA1c level predict the severity of coronary artery stenosis and long-term clinical outcomes in diabetic and nondiabetic patients with acute myocardial infarction undergoing primary angioplasty?
Cohort (n=628)
No
Does admission HbA1c level predict the severity of coronary artery stenosis and long-term clinical outcomes in diabetic and nondiabetic patients with acute myocardial infarction undergoing primary angioplasty?
Effect estimate: R square = 0.012 (95% CI 0.002 to 0.623)
p-value: p=0.049
Admission HbA1c is a useful predictor of the severity of coronary artery stenosis in both diabetic and non-diabetic patients presenting with acute myocardial infarction, though it may not predict 2-year clinical outcomes.
Acute myocardial infarction (AMI) patients with type 2 diabetes mellitus are known to present with multiple vessel lesions during coronary angiography. The underlying mechanism remains elusive and there is a shortage of serum prediction markers. In this study, we investigate the relationship between admission HbA 1c and severity of coronary artery stenosis and subsequent prognosis in AMI patients with or without diabetes. We measured admission HbA 1c , and vessel scores based on the number of diseased coronary vessels with significant stenosis in 628 patients diagnosed with AMI. Simple and multi-regression analysis were performed to investigate the correlation between HbA 1c and the severity of coronary artery stenosis. Major adverse cardiovascular events (MACE), including new-onset myocardial infarction, acute heart failure and cardiac death, were documented during the follow-up. 272 non-DM participants and 137 DM participants were separated into two groups based on HbA 1c levels for survival analysis during a 2-year follow up. 448 non-DM patients and 180 DM patients were included in the initial observational analysis. 272 non-DM patients and 137 DM patients were included in the follow-up survival analysis. The admission HbA 1c level was found to be significantly positively correlated to the number of affected vessels suffering from significant coronary artery stenosis both in DM (R square = 0.012; 95% CI 0.002 to 0.623, P = 0.049) and non DM patients (R square = 0.025; 95% CI 0.009 to 0.289, P = 0.037). Kaplan–Meier survival analysis revealed no significant difference with regard to different HbA 1c levels either in DM or non-DM patients at the end of follow-up. In patients with AMI, admission HbA 1c is an important predictor for the severity of coronary artery stenosis in non-DM and DM patients. Further studies are needed to determine whether longer term follow-up could further identify the prognosis effect of HbA 1c on MACE.
No takes yet. Share an insight, caveat, or question.
She et al. (2017) conducted a cohort in Acute myocardial infarction (n=628). Admission HbA1c vs. Lower HbA1c levels was evaluated on Number of affected vessels with significant coronary artery stenosis in DM patients (R square = 0.012, 95% CI 0.002 to 0.623, p=0.049). Admission HbA1c levels were significantly positively correlated with the number of affected coronary vessels with significant stenosis in both diabetic and nondiabetic patients with acute myocardial infarction, but showed no significant association with long-term clinical outcomes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: